We actively seek to acquire or license marketed products to grow our existing biodefense business and to
establish a commercial presence in other specialty markets. We seek:

 

• Approved specialty pharma products
• Currently procured biodefense products
• Biodefense products with a high likelihood of procurement
• Biodefense products with government funded development

 

Contact us at BD@ebsi.com.

 

 

We have more than 10 preclinical ADAPTIRTM (modular protein technology) mono-specific and multi-specific protein biotherapeutic candidates available for partnering. All our candidates have in vitro data and most include in vivo data and manufacturing proof of concept.

 

ADAPTIR—mono-specific protein biotherapeutic preclinical programs in oncology & autoimmunity.
LEARN MORE

 

ADAPTIR—multi-specific protein biotherapeutic preclinical programs in oncology & autoimmunity.
LEARN MORE

 

 

 

Product Development Partnerships
Partners Product Candidates
Tuberculosis Vaccine (MVA85A) 
H5N1 Pandemic Influenza Vaccine (MVA-H5HA),
H5N1 Pandemic Influenza Monoclonal Antibody (Anti-H5Ha mAb)

 

Government Relationships
Government Agency Product Product Candidates 

U.S. Department of Health and Human Services (DHHS)
National Institute of Allergy and Infectious Diseases (NIAID)
Biomedical Advanced Research and Development Authority (BARDA)
BioThrax®
(Anthrax Vaccine Adsorbed)

NuThraxTM
(Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant)
  PreviThraxTM
(Recombinant Protective Antigen Anthrax Vaccine, Purified)
  ThravixaTM
(Fully Human Anthrax Monoclonal Antibody)
  AnthrivigTM
(Human Anthrax Immunoglobulin)
Centers for Disease Control (CDC) BioThrax®
(Anthrax Vaccine Adsorbed)		  
U.S. Department of Defense (DoD)


Joint Program Executive Office Chemical and Biological Medical Systems (JPEO-CBMS)		 BioThrax®
(Anthrax Vaccine Adsorbed)		  

 

Submit your inquiry! BD@ebsi.com

MEET US

  • Investor Relations

    Bank of America Merrill Lynch 2013 Health Care Conference
    May 14 - 16
    Las Vegas, NV

  • Biodefense

    11th Annual Emerging Infectious Diseases & Biodefense
    June 17 - 19
    Washington, DC

  • Oncology

    ASCO - American Society of Clinical Oncology
    May 31 - June 4
    Chicago, IL

  • Investor Relations

    Credit Suisse First Annual Antibody Day
    May 10
    New York, NY

  • Investor Relations

    Jefferies 2013 Healthcare      Conference
    June 2 - 6
    New York, NY

  • BioSciences

    18th Congress of EHA
    June 13 - 16
    Stockholm, Sweden

© 2012 Emergent BioSolutions Inc. All rights reserved. ABOUT | PRODUCT | PIPELINE | PARTNERING | INVESTORS | CAREERS | NEWSROOM | CONTACT US | TERMS OF USE | PRIVACY POLICY